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Introduction
The increased incidence of both mucosal and
invasive fungal infections during the past two
decades, and the emergence of previously uncom-
mon opportunistic pathogens, necessitates an
ongoing education process with respect to the
microbiology, epidemiology and pathogenesis of
these organisms in order to take full advantage
of the options for prevention and treatment of
systemic fungal infections. Attention to global
trends and continued surveillance remains neces-
sary in order to monitor pathogen frequency and
changes in the activity of antifungal agents. The
prognosis for the patient population depends on
early recognition of the entities involved, prompt
initiation of appropriate therapy and adjunct
surgical management when necessary. Early
detection and the possibility of prophylaxis will
clearly remain at the forefront of future investi-
gation and study. The crucial balance between
diagnosis and treatment is best maintained when
optimal therapy is made available to those
patients who need it, and when those who do
not are clearly identiﬁed rather than exposed to
antifungal agents unnecessarily.
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